We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Germany’s Drug Price Proposal Draws Ire of Merck Chairman
Germany’s Drug Price Proposal Draws Ire of Merck Chairman
April 15, 2010
Merck KGaA says the German government’s proposed changes to the nation’s drug-pricing system amount to regulatory overkill and will hurt efforts
to bring new drugs to market.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor